Bonifacio, Rica Mae C.
HRN: 21-42-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2022
CEFUROXIME 500MG (TAB)
06/20/2022
06/27/2022
ORAL
500mg
Q12
S/P NSVD; Thickly Meconium Stained Amniotic Fluid, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes